Finally, the expression of ISG56 in the nasopharyngeal swab samples of COVID-19 patients exhibited a lower induction than that of DDC in patients with mild symptoms, whereas the group of patients with severe symptoms had equal ISG56 mRNA levels with the non-COVID-19 group (Negative). This evidence concerns the gene IFIT1 and COVID-19.